Increased levels of fucosyltransferase IX and carbohydrate Lewis(x) adhesion determinant in human NT2N neurons.
The expression of the fucosylated carbohydrate Lewis(x) (Le(x)) determinant (Gal(beta1-4)[Fuc(alpha1-3)]GlcNAc-R) has been found in glycoproteins, proteoglycans, and glycolipids from the nervous system. Evidence suggests its association with cell-cell recognition, neurite outgrowth, and neuronal migration during central nervous system development. In the present work, we detected increased levels of Le(x) in differentiated human NT2N neurons cultured in vitro. To identify which fucosyltransferase (FUT) synthesized the Le(x) in NT2N neurons, RT-PCR, FUT substrate specificity and Western blot analysis were carried out. Strong activity toward acceptors Galbeta4GlcNAc-O-R and Fucalpha2Galbeta4GlcNAc-O-R [R = -(CH(2))(3)NHCO(CH(2))(5)NH-biotin], together with strong FUT9 detection by Western blot and presence of transcripts showed that FUT9 was the enzyme associated with Le(x) biosynthesis in NT2N neurons. Le(x) was detected at the plasma membrane of NT2N neurons, in lysosomes marked with lysosomal-associated membrane protein 1 (LAMP-1), and it was found for the first time to colocalize with the tetanus neurotoxin-insensitive vesicle-associated membrane protein (TI-VAMP) that defines the TI-VAMP exocytic compartment that is involved in neurite outgrowth. Furthermore, incubation with anti-Le(x) monoclonal antibody L5 led to impaired adhesion of NT2N neurons to the surface matrix and inhibited neurite initiation. In conclusion, FUT9 and its product Le(x) are detected specifically in human NT2N neurons and our results indicate that they underlie cell differentiation, cell adhesion, and initiation of neurite outgrowth in those neurons.
Brito
Catarina
C
Instituto de Tecnologia Química e Biológica, Oeiras, Portugal.
Escrevente
Cristina
C
Reis
Celso A
CA
Lee
Virginia M-Y
VM
Trojanowski
John Q
JQ
Costa
Júlia
J
D000906:Antibodies / Q000494:pharmacology; D050260:Carbohydrate Metabolism / Q000187:drug effects / Q000502:physiology*; D002240:Carbohydrate Sequence; D002241:Carbohydrates / Q000737:chemistry; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D005647:Fucosyltransferases / Q000378:metabolism*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D016256:Lewis X Antigen / Q000737:chemistry* / Q000276:immunology / Q000378:metabolism*; D052118:Lysosomal-Associated Membrane Protein 1 / Q000378:metabolism; D016501:Neurites / Q000187:drug effects; D009447:Neuroblastoma / Q000473:pathology; D014212:Tretinoin / Q000494:pharmacology; D033921:Vesicular Transport Proteins / Q000378:metabolism
D000906:Antibodies; D002241:Carbohydrates; D016256:Lewis X Antigen; D052118:Lysosomal-Associated Membrane Protein 1; C114051:VAPA protein, human; D033921:Vesicular Transport Proteins; D014212:Tretinoin; C519500:FUT9 protein, human; D005647:Fucosyltransferases